Serotonin function in panic disorder: important, but why? (Q36244896)

13 August 2017

1 reference

title

Serotonin function in panic disorder: important, but why? (English)

1 reference

13 August 2017

1 reference

2

Jakov Shlik

1 reference

13 August 2017

1

Eduard Maron

1 reference

PubMed ID

16132063

13 August 2017

language of work or name

English

0 references

publication date

1 January 2006

1 reference

13 August 2017

Neuropsychopharmacology

1 reference

13 August 2017

31

1 reference

13 August 2017

1-11

1 reference

13 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300880

13 August 2017

0 references

cites work

A review of central 5-HT receptors and their function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Tryptophan depletion and its implications for psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Pharmacologic effect of imipramine, paroxetine, and sertraline on 35% carbon dioxide hypersensitivity in panic patients: a double-blind, random, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

5-HT1A responsivity in patients with panic disorder before and after treatment with aerobic exercise, clomipramine or placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Serotonin function in panic disorders. The effect of intravenous tryptophan in healthy subjects and patients with panic disorder before and during alprazolam treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Serotonin function in anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Brain circuits in panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

A phase II multicenter dose-finding, efficacy and safety trial of ipsapirone in outpatients with generalized anxiety disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Behavioral, neuroendocrine, and biochemical effects of 5-hydroxytryptophan administration in panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

PET imaging of serotonin 1A receptor binding in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Serotonergic polymorphisms in patients suffering from alcoholism, anxiety disorders and narcolepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

5-HT1A receptors and 5-HT1A-mediated responses: effect of treatments that modify serotonergic neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Response to meta-chlorophenylpiperazine in panic disorder patients and healthy subjects: influence of reduction in intravenous dosage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Effects of tryptophan depletion in panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Neuroanatomical hypothesis of panic disorder, revised

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

The endophenotype concept in psychiatry: etymology and strategic intentions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

The neuroanatomy of 5-HT dysregulation and panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Serotonin transporter genetic variation and the response of the human amygdala

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Fenfluramine, cortisol, and anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Human 5-HT1A receptor C(-1019)G polymorphism and psychopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Positive association between panic disorder and polymorphism of the serotonin 2A receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

L-5-hydroxytryptophan in the treatment of anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Pituitary hormone responses to meta-chlorophenylpiperazine in panic disorder and healthy control subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Behavioral indications for serotonin receptor hypersensitivity in panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Effects of tryptophan depletion on anxiety and on panic provoked by carbon dioxide challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Anxiogenic effects of m-CPP in patients with panic disorder: comparison to caffeine's anxiogenic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Effect of acute tryptophan depletion on behavioral, cardiovascular, and hormonal sensitivity to cholecystokinin-tetrapeptide challenge in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Variability of 5-HT2C receptor cys23ser polymorphism among European populations and vulnerability to affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Focus on The 5-HT1A receptor: emerging role of a gene regulatory variant in psychopathology and pharmacogenetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

The spectrum of behaviors influenced by serotonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

A comparison of trazodone and fluoxetine: implications for a serotonergic mechanism of antidepressant action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Reduced brain serotonin transporter binding in patients with panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Associations between serotonin-related gene polymorphisms and panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Association study of 90 candidate gene polymorphisms in panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Association between serotonin-related genetic polymorphisms and CCK-4-induced panic attacks with or without 5-hydroxytryptophan pretreatment in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

The effect of 5-hydroxytryptophan on cholecystokinin-4-induced panic attacks in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Effects of the 5-HT3 antagonist, ondansetron, on the behavioral and physiological effects of pentagastrin in patients with panic disorder and social phobia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Fluoxetine, but not tricyclic antidepressants, potentiates the 5-hydroxytryptophan-mediated increase in plasma cortisol and prolactin secretion in subjects with major depression or with obsessive compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Effect of acute tryptophan depletion on CO2-induced anxiety in patients with panic disorder and normal volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

d-Fenfluramine in panic disorder: a dual role for 5-hydroxytryptamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Reduced serotonin type 1A receptor binding in panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Relationship between panic disorder and agoraphobia. A family study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Mechanisms of action of selective serotonin reuptake inhibitors in the treatment of psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Lack of relationship between CO2 reactivity and serotonin transporter gene regulatory region polymorphism in panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Antipanic efficacy of paroxetine and polymorphism within the promoter of the serotonin transporter gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Differential expression of the "C" and "T" alleles of the 5-HT2A receptor gene in the temporal cortex of normal individuals and schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Quantitative autoradiography of 5-hydroxytryptamine1A binding sites in rats with chronic neonatal 5,7-dihydroxytryptamine lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Association of a functional 1019C>G 5-HT1A receptor gene polymorphism with panic disorder with agoraphobia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Association study of serotonin-2A receptor gene polymorphism and panic disorder in patients from Canada and Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Association studies of MAO-A, COMT, and 5-HTT genes polymorphisms in patients with anxiety disorders of the phobic spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Evaluating gene x psychological risk factor effects in the pathogenesis of anxiety: a new model approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Effects of tryptophan depletion on carbon dioxide provoked panic in panic disorder patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Acute L-5-hydroxytryptophan administration inhibits carbon dioxide-induced panic in panic disorder patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Lack of effect of antidepressant drugs on the levels of mRNAs encoding serotonergic receptors, synthetic enzymes and 5HT transporter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

The molecular neuroimaging of anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Fenfluramine provocation of anxiety in patients with panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Monoamine oxidase inhibitors in anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Behavioral, neuroendocrine and biochemical effects of different doses of 5-HTP in panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

A common C-1018G polymorphism in the human 5-HT1A receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Tryptophan depletion causes a rapid lowering of mood in normal males.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Tryptophan hydroxylase-2 controls brain serotonin synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Excess of High Activity Monoamine Oxidase A Gene Promoter Alleles in Female Patients with Panic Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Novel 5′-regulatory region polymorphisms of the 5-HT2C receptor gene: association study with panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Increased psychological responses and divergent neuroendocrine responses to m-CPP and ipsapirone in patients with panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

Enhancement of CO2-induced anxiety in healthy volunteers with the serotonin antagonist metergoline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

7 January 2021

L-Tryptophan and prolactin release: Evidence for interaction between 5-HT1 and 5-HT2 receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

7 January 2021

Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

7 January 2021

5 -HT, antidepressant drugs and the psychosocial origins of depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

7 January 2021

5-HT and mechanisms of defence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

7 January 2021

Functional promoter polymorphism of the human serotonin transporter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

7 January 2021

Acute and chronic role of 5-HT3 neuronal system on behavioral and neuroendocrine changes induced by intravenous cholecystokinin tetrapeptide administration in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

7 January 2021

Enhancement in extracellular serotonin levels by 5-hydroxytryptophan loading after administration of WAY 100635 and fluoxetine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

7 January 2021

The HTR1B 861G>C receptor polymorphism among patients suffering from alcoholism, major depression, anxiety disorders and narcolepsy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

7 January 2021

Sex differences in allelic frequencies of the 5-HT2C Cys23Ser polymorphism in psychiatric patients and healthy volunteers: findings from an association study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

7 January 2021

Paradoxical actions of the serotonin precursor 5-hydroxytryptophan on the activity of identified serotonergic neurons in a simple motor circuit

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

7 January 2021

Lack of genetic linkage or association between a functional serotonin transporter polymorphism and panic disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

7 January 2021

No genetic linkage or association between a functional promoter polymorphism in the monoamine oxidase-A gene and panic disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

7 January 2021

No coding variant of the tryptophan hydroxylase gene detected in seasonal affective disorder, obsessive–compulsive disorder, anorexia nervosa, and alcoholism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

7 January 2021

An association study between a transcriptional polymorphism in the serotonin transporter gene and panic disorder in a Japanese population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

7 January 2021

Structure and function of the brain serotonin system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

7 January 2021

Effect of a serotonin precursor and uptake inhibitor in anxiety disorders; a double-blind comparison of 5-hydroxytryptophan, clomipramine and placebo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

7 January 2021

Ventilatory effects of tryptophan depletion in panic disorder: a preliminary report

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

7 January 2021

Impaired Repression at a 5-Hydroxytryptamine 1A Receptor Gene Polymorphism Associated with Major Depression and Suicide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

7 January 2021

Serotonin transporter gene regulatory region polymorphism and panic disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

7 January 2021

Effect of pindolol on the L-5-HTP-induced increase in plasma prolactin and cortisol concentrations in man

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

7 January 2021

Clinical predictors of acute response with olanzapine in psychotic mood disorders.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

7 January 2021

Modification of 35% Carbon Dioxide Hypersensitivity Across One Week of Treatment With Clomipramine and Fluvoxamine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

7 January 2021

Ipsapirone and 1-(2-pyrimidinyl)-piperazine increase rat locus coeruleus noradrenergic activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

7 January 2021

The effects of tianeptine or paroxetine on 35% CO2 provoked panic in panic disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

7 January 2021

Panic and phobic anxiety: defining phenotypes for genetic studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

7 January 2021

Association of a MAOA gene variant with generalized anxiety disorder, but not with panic disorder or major depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

7 January 2021

Effect of the selective serotonin reuptake inhibitor fluvoxamine on CCK-4 induced panic attacks

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

7 January 2021

Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

7 January 2021

Autoradiographic quantification of serotonin1A receptors in rat brain following antidepressant drug treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

7 January 2021

Serotonin function in panic disorder: intravenous administration of meta-chlorophenylpiperazine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300880

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300880

1 reference

13 August 2017

1 reference

PubMed ID

16132063